NFKB1 and arthritic joint disease: In other words, macrophage expression was lowest in the mice of the NF-κB p65 siRNA/LPCE treatment group, thus corroborating the above findings that NF-κB p65 siRNA/LPCE complexes targeted macrophages and suppressed the NF-κB-dependent inflammatory response in the mitigation of clinical arthritis.